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INTRODUCTION 
Spinal cord injury (SCI) is a traumatic insult to the spinal cord that can result in alteration of 
normal motor, sensory and autonomic function. It is one of the most catastrophic injuries 
because of its multi-system involvement. Osteoporosis is a systemic skeletal disease 
characterised by low bone mass and micro-architectural deterioration of bone tissue, with a 
consequent increase in bone fragility and susceptibility to fracture. Persons with SCI 
experience musculoskeletal effects of non-weight bearing throughout their lives. 
Osteoporosis is one of the complications of SCI.  
Considerable magnitude of bone mass lost in the lower limbs following acute SCI (1, 2). 
Prospective studies suggest individuals with SCI can lose up to 40% of their bone mass at 
lower limb sites in the acute post-injury stages (3, 4, 5). The decline in bone density has been 
detected as early as 6 weeks post SCI and has been shown to steadily progress over the next 
12 to 16 weeks before stabilizing. The fracture prevalence in the SCI population has been 
reported to be as great as 70% (6). 
Comprehensive care and early rehabilitation has improved the quality of life of people 
following SCI. However osteoporosis among this group of individuals often predisposes them 
to risk of secondary fractures and related complications. 
Osteoporosis is now widely recognised as a public health problem since this disease, which 
increases bone fragility and thereby the risk of fractures, is associated with high mortality, 
morbidity and medical expenses throughout the world (7).     
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The bone mineral density (BMD) can be measured by Quantitative computerised tomography 
(QCT).QCT allows for a three dimensional true density measurements of bone without super 
imposition of other tissues and therefore provides exact three dimensional anatomic 
localisation of the measured tissue (8). Bone density can be calculated separately in 
trabecular and cortical bone compartments. It makes possible a direct measurement of density 
(gm/cm
3
) at any vertebral site. Selective measurement of high turnover trabecular bone, such 
as the central portion of the vertebral body, is of some advantage because it excludes cortical 
bone and extra osseous calcification.    
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JUSTIFICATION OF THE STUDY 
The majority of the patients who come for rehabilitation under Physical Medicine and 
Rehabilitation here have spinal cord injury. The development of osteoporosis among these 
patients is a concern as in addition to paralysis they have, they are immobilised initially for 2 
to 3 months. The secondary osteoporosis that develops in these patients often predisposes 
them to the risk of secondary fractures and related complications. Radiological studies 
suggest that approximately one third of bone mineral lost within 3-4 months of SCI, after 
which time the loss slows down. The osteoporosis that accompanies SCI patients predisposes 
them to fracture after minor trauma, and the estimated incidence of fracture after SCI is 5 to 
20 %. Fractures in persons with SCI are clinically relevant; they predispose to exuberant 
callus that may cause pressure sores or may mimic infection or thrombosis. Fractures are 
often complicated by profuse diaphoresis and increase in spasticity. In view of the importance 
of trying to prevent this common complication in the SCI population it was decided to 
quantify the incidence of osteoporosis in them during initial immobilisation period. 
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REVIEW OF LITERATURE 
Introduction 
Osteoporosis and associated fractures increase markedly with age and are a major cause of 
mortality and morbidity-and thus of medical expense- throughout world. The combined total 
risk for fracture due to osteoporosis is about 35%. Osteoporosis is a disease that occurs 
commonly in the rehabilitation patient population in its primary and secondary forms (9). 
Osteoporosis is a well recognised complication of SCI and radiological studies suggest that 
approximately one third bone mineral is lost within 3-4 months of SCI, after which time the 
loss slows. Osteoporosis is a disease of the skeletal system characterised by low bone mass 
and deterioration of bone tissue leading to an increased risk of bone fractures (7, 10, 11). 
Persons with traumatic SCI undergo transition immediately from a normal ambulatory life 
style to a state of markedly impaired mobility. Bone mineral loss occurs throughout the entire 
skeleton, except the skull (10). 
Conceptual Definition of Osteoporosis 
Various definition of osteoporosis have been offered to describe the outcome of events 
(fragility fractures), the process giving rise to porous bones, or the resultant diminution in 
bone mass. The following definition is now generally accepted “a disease characterised by 
low bone mass and micro-architectural deterioration of bone tissue, leading to enhanced bone 
fragility and a consequent increase in fracture risk” (7, 13).  
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Operational Definition of Osteoporosis 
The relationship between BMD and fracture risk is continuous, and an estimate of BMD 
therefore provides an effective assessment of fracture risk. It is thus possible to choose a 
value for BMD that defines the presence of osteoporosis. 
Bone mineral content or density (BMC or BMD) in young healthy women (peak bone mass) 
is normally distributed, irrespective of the measurement technique used. By virtue of this 
normal distribution, BMD values in individuals may be expressed in relation to a reference 
population in standard deviation (SD) units; this reduces the problems associated with 
calibration differences between instruments. Use of SD units in relation to the young healthy 
population is referred to as the t-score, where the mean is ascribed a value of zero. 
The World Health Organisation has proposed two diagnostic thresholds of BMD for 
Caucasian women, based on the distribution of skeletal mass in young healthy individuals; 
these thresholds permit the establishment of four general diagnostic categories (14). 
1. Normal: A value for bone mineral within 1 SD of the young adult reference mean.  
(t-score ≥ - 1.0) 
2. Low bone mass (osteopenia) : A value for bone mineral more than 1 SD below the 
young adult  mean but less than 2.5 SD below this value. (t-score -1.1 to - 2..5) 
3. Osteoporosis: A value for bone mineral 2.5 SD or more below the young adult mean. 
(t-score ≥ - 2.5) 
4. Severe (established) osteoporosis: A value for bone mineral 2.5 SD or more below the 
young adult mean in the presence of one or more fragility fractures. 
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Suitable diagnostic cut-off values for non-caucasian women and for men are less secure. It 
has been suggested that a similar absolute value for BMD to that used in women can be taken 
as a cut-off point for the diagnosis of osteoporosis in mean- that is, a value 2.5 SD below the 
average for adult pre menopausal women. It should be recognised that cut-off values are 
arbitrary and may differ according to sites measured, age and type of equipment. 
Thus, the decrease in bone mass with changes in micro-architecture and consequent increased 
fragility represents the disease, whereas low-energy fractures represent a complication of the 
disease that will occur when the force applied to  a bone, such as that resulting from falling, 
exceeds its load-bearing capacity (7). Thus, the osteoporotic fracture depends upon several 
internal and external factors that are not directly related to the osteoporotic process. 
Classification of Osteoporosis (9) 
Osteoporosis can be classified according to localisation in the skeleton and aetiology. 
Localised osteoporosis affects part of the skeleton; generalised osteoporosis affects, to a 
greater or lesser extent, different parts of the whole skeleton. Both types of osteoporosis can 
further be classified into primary and secondary osteoporosis. 
1. Primary Osteoporosis: basic aetiology unknown, no associated disease 
a. Postmenopausal : elderly women 
b. Senile osteoporosis: elderly men   
2. Secondary Osteoporosis: secondary to inherited or acquired abnormalities/diseases 
a. Hyperparathyroidism 
b. Cushing‟s disease 
c. Multiple myeloma 
d. Hyperthyroidism (endogenous and iatrogenic) 
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e. Idiopathic hypercalciuria 
i. Due to renal calcium leak 
ii. Due to renal phosphate leak 
f. Malabsorption (including partial gastrectomy) 
g. 25-OH vitamin D deficiency 
i. Due to chronic liver disease 
ii. Due to chronic anticonvulsant therapy (phenytoin, barbiturates) 
h. 1,25-OH vitamin D deficiency 
i. Due to chronic renal failure 
i. Adult hypophosphatemia 
j. Osteogenesis imperfecta tarda 
k. Male hypogonadism (Klinefelter‟s syndrome) 
l. Female hypogonadism (Turner‟s syndrome) 
m. Conditions consistent with hypoestrogenism secondary to anorexia and/or 
exercise 
i. Anorexia nervosa 
ii. Exercise induced amenorrhoea 
n. Condition associated with disuse 
i. Paraplegia/hemiplegia 
ii. Immobilisation 
iii. Prolonged bed rest 
o. Alcoholism 
p. Diabetes Mellitus 
q. Rheumatoid arthritis 
r. Chronic obstructive pulmonary disease 
11 
 
s. Systemic mastocytosis 
t. Condition associated with the use of medications 
i. Corticosteroids 
ii. Heparin 
iii. Anticonvulsants 
iv. Excess thyroid hormone 
u. Malignancy 
 Aetiology and risk factors 
Osteoporosis fracture risk is dependent on an individual‟s peak bone mass and strength of 
bone achieved in one‟s life time and the subsequent rate of bone loss. Multiple etiologic 
factors may act independently or in combination in an individual patient to produce 
diminished bone mass. 
Risk factors for fractures (9) 
Personal history of low-impact fractures 
Current low bone mineral density 
History of fracture in a first degree relative 
Caucasian race 
Advanced age 
Female sex 
Dementia 
Recurrent falls 
12 
 
Inadequate physical activity 
Poor health/ frailty 
Current smoker 
Low body weight 
Oestrogen deficiency 
Corticosteroid use 
Testosterone deficiency 
Vitamin D deficiency 
Low life time calcium intake 
Alcoholism 
Impaired eye sight despite correction 
Pathogenesis (15) 
The pathogenesis of osteoporosis is complex in childhood and adolescent period; rate of bone 
formation exceeds resorption, resulting in continued skeletal growth and denser, longer and 
heavier bones. This process slows down in adulthood and peak bone mass is attained at about 
30 years of age. After this, resorption begins to exceed formation. Normal bone loss averages 
0.7% per year. It gets accelerated at the time of menopause to 2-5 % per year, which may 
continue for up to 10 years. Since cancellous bone loss is metabolically much more active 
than cortical bone, in periods of accelerated bone loss cancellous bone loss is three fold 
greater. Osteoporotic fractures therefore commonly occur in vertebrae.  
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Peak bone mass is primarily determined by genes but may be modified to a considerable 
extent by factors such as physical activity, calcium, vitamin d nutrition, smoking, alcohol, 
concurrent illness and medications- glucocorticoids and antiepileptics. The level of peak bone 
mass achieved at puberty is a major determinant of bone mass in later life and hence an 
important factor in the ultimate development of osteoporosis. 
Cellular abnormalities 
Conclusive evidence of cellular abnormalities contributing to the pathogenesis of 
osteoporosis is lacking. It may be that failure of osteoblast (the cell responsible for bone 
formation), due to either decreased cell number or decreased cell activity, may accompany 
advancing age but is not specific for osteoporosis (9). 
Diagnosis 
The first clinical indication of osteoporosis, either primary or secondary, will usually be a 
fracture. An absolute diagnosis of osteoporosis is usually made when an atraumatic fracture 
occurs in the presence of low bone mass (most typically of the spine, femur, and/or distal 
radius). However it is obviously of value from the standpoint of patient management to 
evaluate the patient at risk for the fracture before a fracture occurs, as well as to determine the 
cause of the fracture in patients in whom a fracture has occurred. Because the amount of bone 
mass present is the principal determinant of fracture, a non-invasive technique for quantifying 
bone mass would consequently be of value not only in the diagnosis of osteoporosis, but also 
in following a response to therapy. 
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Methods for measuring bone mass 
Bone mass measurements and biochemical markers of bone turnover are key methods to 
diagnose osteoporosis, predict future fracture, and monitor therapeutic regimens. 
Biochemical markers of bone turnover 
Markers of bone formation 
Serum 
 Osteocalcin 
 Bone specific alkaline phosphatase 
Markers of bone resorption  
Plasma 
 Tartrate-resistant acid phosphatise 
 Free pyridinoline and deoxy pyridinoline and type I collagen N and C- telopeptides 
breakdown products 
Urine 
 Urinary pyridinoline and deoxypyridinoline (collagen cross links) and type I collagen 
N and C – telopeptides breakdown products 
 Fasting urinary calcium and hydroxyproline 
 Urinary hydroxylysine glycosides 
Roberts et al (16) demonstrated a dramatic rise in bone resorption markers, beginning within 
the first week of injury and peaking around weeks 10 to 16. Depending on the resorption 
marker examined, the peak was as high as 10 times the upper limit of normal.  
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Values had not returned to baseline at 6 months, indicating ongoing loss of bone. Contrasting 
with large rise in resorption markers, the change in markers of bone formation was modest 
and barely exceeded the reference range. 
Quantification  of bone mass 
Most commonly used techniques 
1. Single and dual photon absorptiometry (SPA and DPA respectively) 
2. Quantitative computed tomography 
3. Single or dual energy x-ray absorptiometry 
4. Peripheral quantitative computed tomography 
5. Ultra sound 
Attenuation or absorption of ionising radiation by bone is the basic principle used in the 
majority of the noninvasive techniques (with the exception of ultrasound). A generally linear 
relationship exists between bone mass and radiation attenuation: the greater the amount of 
bone present, the greater the attenuation of ionising radiation, and subsequently the less 
radiation quantitated in a detector (9). 
DXA is the clinical „gold standard‟ for diagnosing osteoporosis (17). DXA allows the 
measurement of bone mineral density in the axial and peripheral skeleton. Bone density 
measurements can be obtained within 30 seconds to 2 minutes with a radiation exposure of 
approximately 10 m rad (one-sixth the exposure of a chest x-ray) with 99% precision and 
approximately 97% accuracy (9). However, the DXA technology for diagnosing osteoporosis 
by measuring bone density became available in India only in 1997 (15). 
 
16 
 
Quantitative computed tomography (QCT) 
QCT allows for a three-dimensional true density measurement of bone without 
superimposition of other tissues and therefore provides exact three-dimensional anatomic 
localisation of the measured tissue (18). Bone density can be calculated separately in 
trabecular and cortical bone compartments. QCT is widely available now as a standard 
clinical examination of the bone density of the lumbar spine. Selective measurement of high 
turnover trabecular bone, such as the central portion of the vertebral body, is of some 
advantage because it excludes cortical bone and extra osseous calcification. 
Single energy QCT is usually applied for routine examinations. A low dose, low energy 
exposure resulting in an effective dose of typically 50 uSv (including lateral digital 
radiograph) with essentially no gonad exposure. Dual energy QCT can improve accuracy, but 
technical considerations and a higher radiation dose limit this technique‟s use to research 
applications. 
QCT not only provides information on BMD, but also on bone structure for the regions 
examined. QCT results are expressed as mgm of K2HPO (dipotassium hydrogen 
orthophosphate) per cubic cm of bone volume, reflecting a true three dimensional density 
rather than the two dimensional area of DXA. 
Interpretation of BMD analysis report  
The measurements, which are carried out to three decimal places are given in mg per cubic 
cm. They are used to determine the T score and the Z score. The T score assesses the risk of 
fracture. It compares the subject‟s BMD with the predicted mean peak BMD (in an average 
30 year old of the same sex) and expresses the difference in standard deviation (SD). In other 
words, the T score shows how the subject‟s BMD compares with ideal level.  
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A patient who‟s BMD is 1SD below that of an average 30 year old has a T score of -1. The Z 
score determines whether the subject‟s bone loss is out of proportion with what is expected. It 
compares the subject with the mean for age matched, sex matched and ethnic matched 
controls and express the difference in SD. Thus a 70 year old woman with a Z score of -1 is 1 
SD below the BMD of the average 70 year old woman, but her T score is -3 because she is 3 
SD below the BMD of the average 30 year old woman. The T score is useful in assessing a 
patient‟s risk of fracture and deciding whether to recommend pharmacological therapy. In 
general, almost all patients whose BMD is in the osteoporotic range should be considered for 
such therapy. Many patients with values in the osteopenic range, particularly those in the 
lower end of the range or with several risk factors for fracture, should also be considered for 
pharmacological therapy.  
In a meta-analysis of how well measures of bone mineral density predict occurrence of 
osteoporotic fractures, Marshal et al concluded that BMD can identify people who are at 
increased risk of developing a fracture, but it cannot with any certainty identify individuals 
who will develop a future fracture (19). It was also found that most measuring sites (proximal 
radius, distal radius, hip, lumbar spine, calcaneus and all sites) had virtually the same 
predictive ability for a decrease of 1 SD in bone density.  
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Figure 1: QCT - BMD report 
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Management of Osteoporosis 
Because osteoporosis results in fractures due to minimal trauma, rapidly effective therapy is 
required to reduce fracture (20).Treatment of osteoporosis includes pharmacological and non-
pharmacological methods. 
Non-Pharmacological treatment 
The avoidance of lifestyles known to result in bone loss, including cigarette smoking, 
excessive alcohol intake, lack of exercise, and so forth, should be addressed along with 
recommendations for nutritional and pharmacologic therapy (9). Morse et al reported that 
increased alcohol consumption after SCI may exacerbate sub-lesion bone loss (21). 
Fall prevention 
A multifactorial approach that addresses vision deficits, balance and gait abnormalities, 
cognitive impairment and dizziness is the cornerstone of fall prevention. Improving lighting, 
removing loose rugs and adding grab bars near bathtubs, toilets and stairways can enhance 
safety (22). 
Nutritional adjuncts 
Calcium 
It is a mainstay of osteoporosis prevention and treatment. Recommended minimum calcium 
intake is 1000 to 1500 mg/day in all peri menoupausal and post menoupausal women and for 
men is 800 mg to 1500 mg. Calcium is generally safe (in the absence of a history of previous 
kidney stones, or of idiopathic hypercalciuria), comparatively inexpensive and logistically 
simple to ingest. A predisposition for kidney stones and nephrolithiasis may be seen.  
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A urinary calcium excretion of up to 250 mg per 24 hours is acceptable in individual without 
a history of kidney stones (9). 
Vitamin D 
400 to 800 IU per day of vitamin D is recommended. This will help to increase calcium 
absorption at the gut level, and use of active form of vitamin D analog as calcitriol may result 
in increased risk for kidney stones or for hypercalciuria, nephrolitiasis, or even 
nephrocalcinosis (9). 
Protein 
Along with calcium and vitamin D supplementation, it has been shown favourable outcomes 
in patients who have sustained hip fractures. RDA for protein is 44 g/day for women and 56 
g/day for men (9). 
Pharmacological treatment 
The treatment of osteoporosis and osteopenia is directed at preservation or improvement of 
bone mass at the specific target sites.  Because bone mass is the principal, although not the 
only, determinant of fracture, such preservation or improvement of bone mass is associated 
with a reduced risk of fracture. The axial and appendicular sites exhibit varying proportions 
of cortical (compact) and trabecular (cancellous) bone. Trabecular bone is metabolically more 
active than cortical bone (9). Trabecular bone appears to be preferentially altered in 
osteoporosis and is the type of bone most affected by medications used in the treatment of 
osteoporosis. A number of US FDA approved therapeutic agents are available to decrease 
bone resorption (anti bone resorbs). There are also a number of therapeutic modalities that 
increase bone formation (positive bone formers) (9). 
 
21 
 
Antiresorptive agents 
Among the antiresorptive drugs, the predictive value of preclinical studies has been 
particularly well documented with the bisphosphonates. 
Bisphosphonates 
These are primary agents in the current pharmacological arsenal against osteoclast mediated 
bone loss due to osteoporosis, paget‟s disease of bone, malignancies metastatic to bone, 
multiple myeloma, and hypercalcemia of malignancy (23). Structurally, bisphosphonates are 
chemically stable derivatives of inorganic pyrophosphate, a naturally occurring compound in 
which 2 phosphate groups are linked by esterification. It is the most commonly used 
treatment for established osteoporosis, inhibits osteoclast mediated bone resorption and 
reduces the risk of vertebral fracture. Maimoun et al cited that bisphosponates reduce bone 
loss in both the early and chronic phases of SCI, even though the demineralisation process 
cannot be stopped (24). 
Oestrogen    
Oestrogen is also approved by FDA for preventing osteoporotic fractures in post 
menoupausal women. The evidence suggests that oestrogen reduces the risk for vertebral and 
hip fracture; however, the effect of oestrogen on nonvertebral fracture risk is less clear. 
Selective estrogen receptor modulators 
Selective oestrogen receptor modulators have been developed to provide beneficial effects 
similar to those obtained with oestrogen, but without the adverse effects. The common SERM 
used are Tamoxifen, Raloxifen. Raloxifen has oestrogen agonist activity on the bones and 
lipids and an oestrogen antagonist effect on the breast and uterus.  
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Raloxifen is effective for reducing the incidence of vertebral fractures, but effectiveness at 
the hip has not been shown (25). 
Salmon Calcitonin 
Both intranasal and injectable forms of salmon calcitonin (Miacalcin) approved for the 
treatment of postmenopausal osteoporosis. Calcitonin inhibits bone resorption and is 
recommended for use in women with osteoporosis who are at least five years past menopause 
and cannot take other agents (20). 
Adherence to osteoporosis treatment 
The term „adherence‟ comprises both compliance and persistence to treatment. „Compliance‟ 
refers to how the medication is taken or quality of intake. „Persistence‟ is defined as the time 
from initiation to discontinuation of treatment (26).  
Anabolic agents (positive bone formers) 
Parathyroid hormone 
Parathyroid hormone, or fragments of the intact peptide molecule, may be of value in 
osteoporosis when administered parenterally. Such a usage is based on a presumed anabolic 
effect of parathyroid hormone when administered as a fragment, and it may be of value in 
established osteoporosis in terms of stimulating bone formation. The FDA approved the use 
of parathyroid hormone for the treatment of osteoporosis in 2002 (9). 
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Recombinant human parathyroid hormone (teriparatide) 
Teriparatide (Foreto) is a recombinant human parathyroid hormone with potent bone anabolic 
activity (25).  
It is approved for the treatment of postmenopausal women with severe bone loss, men with 
osteoporosis who have a high risk of fractures and persons who have not improved on 
bisphosphonate therapy (9). In a dosage 20 mcg per day given subcutaneously for up to 2 
years shows some benefits. 
Fluoride 
Fluoride as sodium salt has been introduced in the therapy of human osteoporosis without any 
well documented preclinical assessment of the relationship between bone mass and strength. 
Experimental Therapies 
Anabolic steroids 
These currently experimental agents may actually have a beneficial effect on bone mass; their 
side effects include liver toxicity, masculinisation and an increased cholesterol level. 
Testosterone 
This may be of value in the treatment of osteoporosis in elderly men, particularly those with 
hypogonadism. Prostate and cholesterol status should always be checked when using 
testosterone (9). 
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Osteoporosis in spinal cord injury 
Osteoporosis is a known consequence of SCI and occurs in almost every patient (27). The 
significance of osteoporosis after SCI is that it results in skeletal fragility and an increased 
risk of fractures. Complications from fractures lead to an increase not only in the associated 
morbidity and mortality, but also in the health care costs that they generate. These fractures 
predispose to exuberant callus that may cause pressure sores or may mimic infection or 
thrombosis.  
Fractures are often complicated by profuse diaphoresis and an increase in spasticity (16). The 
porous nature of bones means that surgical fixation is often difficult; conservative treatment 
with plaster casts can result in pressure sores. Vestergaard et al found that low energy 
fractures were much more prominent in patients (19% of all fractures) than in controls (28). 
The fracture rate did not differ before the injury but increased after the injury to a constant 
level from the third year and forward. Fractures of the lower extremities were more 
prominent in patients than controls while fractures of the forearms and clavicles were absent 
among patients. Fractures were more frequent in female patients than in male patients with a 
family history of fracture. 
The pattern of bone loss seen in SCI patients is different from that in osteoporosis, which 
occurs as a result of other aetiologies such as endocrine disease, nutritional disorders and 
drug-related factors (27). 
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Mechanism of bone loss in SCI 
The effect of mechanical loading on bone tissue is an increase in bone formation on the 
periosteal bone surfaces, thus improving bone strength and reducing bone turnover and bone 
porosity (10). Consequently, mechanical loading can improve both bone size and shape and 
strengthen the bone tissue by improving tissue density. 
Unloading 
Kondo et al revealed that sympathetic nervous tone is mediating unloading induced bone loss 
via reduction in osteoblastic cell activity as well as enhancement in osteoclastic cell activity 
(29). SCI caused unloading and restricted movement of the lower limb joints for substantial 
periods of time and substantial muscle atrophy has been seen in SCI patients. Unloading may 
play an important role in the development of osteoporosis after SCI (30). 
Neuronal changes- denervation 
Innervation of bone is reported to have trophic effects on bone metabolism and a growing 
number of experimental and clinical studies indicate that innervations is important for bone 
remodelling (10). Similarly, SCI may lead to a significant decrease in innervation density and 
neuropeptides in the sublesional bones, thus distorting that balance of bone formation and 
resorption. In addition to the direct role of denervation on bone metabolism, denervation after 
SCI can cause disordered vasoregulation, thus affecting bone remodelling. 
Hormonal changes 
Although upper limbs are normally loaded and innervated, bone loss also occurs in the upper 
extremities in patients with paraplegia. Therefore, systemic hormones such as PTH, Vitamin 
D3, sex steroids, thyroid hormone and leptin may also be involved in bone loss following SCI 
(10). 
26 
 
Calcium balance 
In general, SCI patients showed negative calcium balance with hypercalciuria after the injury 
(31). The increased osteoclastic bone resorption is mainly responsible for hypercalciuria 
following SCI. Exercises and ambulation significantly decreases the hypercalciuria and 
modifies the calcium balance in a positive direction, indicating that immobilisation may be an 
important factor resulting in this negative calcium balance (32). 
PTH and Vitamin D 
Secretion of PTH and increase in circulating 1,25 (OH)2 vitamin D are subjected to control by 
negative feedback mechanisms related to serum calcium level (10). In addition, 
hypercalcemia after injury may lead to this PTH-vitaminD axis suppression in the acute 
phase of SCI. 
PTH suppression in SCI patients is also associated with the degree of neurological 
impairment. In a cross sectional study, Machanick et al investigated serum PTH and 1,25 
(OH)2 vitamin D levels in SCI patients who were tested at a mean of 76.5 days post injury, 
and found that patients with complete SCI, when compared to those with incomplete injury, 
had a greater suppression of the PTH-Vitamin D axis (33). However, a reversal in parathyroid 
activity from 1 to 9 years after injury has been noted. 
Effects on gonad function 
Sex steroids play a pivotal role in regulating bone remodelling. Thus, a decrease in the 
circulating concentrations of these hormones increases osteoclast precursor formation in the 
bone marrow and thus increases the number of mature osteoclasts in cancellous bone (35). 
Maimoun et al reported recently that total testosterone and the free androgen index were 
significantly lower in SCI patients than in able bodied controls (36). 
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Management of osteoporosis in SCI 
Morse et al cited that, although admission for osteoporotic fractures accounted for only 2.6% 
of the admissions, these hospitalisations resulted in longer lengths of stay than other 
admissions and individuals also required increased levels of assistance for transfers and self 
care during immobilisation of a fractured limb. Hence prevention of fractures would therefore 
decrease the health care costs and promote independence in this population (21). 
Non Pharmacologic management 
Prevention of falls 
Morse et al also found that the most common cause of fracture in chronic SCI injury was 
falls, which may be difficult to prevent (21).  
However, based on record review, 20% of fractures resulting in hospitalisation were due to 
transfer and wheel chair ambulation technique. It may be possible to reduce fracture risk by 
improving counselling and educating patients regarding limb protection during various self 
care activities and reinforce the importance of adequate doorway width for wheel chair 
clearance. 
Standing-up and orthotic aided walking 
The study by De Bruin et al indicates that early mobilisation led to no or insignificant loss of 
trabecular bone, where as the immobilised individuals showed a marked decrease when 
monitored for 25 weeks (37). In addition, the recent study by Alekna et al found that 
standing, particularly after 2 years, gave significantly higher BMD in legs, pelvis and the 
total body (38). 
 
28 
 
Physical exercise 
The quality of evidence available for evaluation is poor (39). Miyahara et al found that the 
earlier the athlete started sports after injury, the higher the BMD of the legs, body, trunk and 
entire body (40). Further, a longer period of athletic career after restarting was significantly 
related to higher leg BMD. 
Functional electrical stimulation 
Functional electric stimulation is a method of exercise that has been employed in the SCI 
population that has demonstrated some success in improving muscle, with less conclusive 
evidence that it has a positive effect on bone (17). Be dell et al demonstrated that there was 
no significant increase in bone density in the hip parameters of chronic SCI patients after 
functional electrical stimulation induced lower extremity cycling, though a positive trend was 
observed in the lumbar spine (41).  
Gianggregario et al demonstrated that 9 months of thrice weekly FES cycle ergometry failed 
to increase BMD at the femoral neck, distal femur and proximal tibia in individuals with 
complete SCI (17). 
Low intensity pulsed ultrasound 
Naruse et al demonstrated that low intensity, pulsed ultra sound, which has been clinically 
used to accelerate the healing process of fractured bone, induces a direct anabolic reaction of 
osteogenic cells, leading to bone matrix formation (42). Warden et al applied specific ultra 
sound at the calcaneum for 6 weeks in young subjects with 1-6 month histories of complete 
SCI (43). The results showed that low intensity pulsed US were unable to protect against SCI 
induced calcaneal bone demineralisation. Further investigations are needed. 
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Pharmacological Management 
The physiopathological data have shown that bone demineralisation in patients with SCI can 
be principally attributed to an alteration of the bone remodelling process that dramatically 
favours an increase in bone resorption. Drug treatment thus mostly consists of substances that 
inhibit osteoclast cell activity (24). 
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AIMS AND OBJECTIVES 
Determine incidence of vertebral osteoporosis following acute spinal cord injury. 
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MATERIALS AND METHODS 
Study design: Descriptive study 
Patients with tetraplegia or paraplegia getting admitted under the department of Physical 
medicine and Rehabilitation, Christian Medical College Hospital, Vellore for rehabilitation 
within 2 weeks following acute spinal cord injury were included in this trial. 
                     20 patients aged between 20 to 40 years including both male and female admitted 
within 2 weeks following traumatic acute spinal cord injury with paraplegia or tetraplegia were 
included in this study and observed over a period of 20 weeks.  
                    The study in detail was presented to the ethical review committee of the CMC 
Hospital and permission was obtained. Before recruiting the patients for this study, they were 
explained about the nature of the injury, nature of the study and details of the study plan.  An 
informed consent to participation was obtained from all patients in accordance with Helsinki 
ll Declaration. 
Inclusion and Exclusion criteria 
1. Inclusion Criteria: 
     i. Any patient with acute traumatic SCI (paraplegic or tetraplegic) who is  
         admitted within 2 weeks of traumatic spinal cord injury. 
     ii. Age group of 20-40 years. 
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2. Exclusion Criteria: 
     a. Patients with internal fixation for the vertebral fractures. 
     b. Patients with any chronic illness like Chronic Renal Failure (Contracted     
          kidneys in the ultrasound and serum creatinine >1.5 mg%), history of  
          malabsorption etc. 
     c. Patients taking drugs regularly for other diseases, which are likely to develop  
         osteoporosis (e.g. steroids, anti-inflammatory agents etc.) 
     d. Patient who is not able to give informed consent. 
          Immediately after the admission a detailed history and clinical evaluations were done. 
A baseline bone mineral density was done at the time of admission.  In addition to the routine 
investigations the following investigations were done to rule out other possible causes of 
secondary osteoporosis. 
    1.  Serum calcium & serum phosphorus 
    2.  24- hour urinary calcium 
    3.  Serum creatinine 
    4.  Serum total protein and albumin 
    5.  Serum alkaline phosphatase 
    6.  PCV 
    7.  Serum sodium, potassium, and bicarbonate 
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    8.  Ultrasound abdomen 
    9.  X-ray thoraco lumbar spine 
 Sample size 
             Power calculation shows, if we study 20 patients, we have 80% power to detect 30 
mg/cc change in BMD from normal and >90% power to detect >50 mg/cc change in BMD. 
Normal BMD values and standard deviation of this value was obtained from QCT data. 
Measurements: 
             Spinal bone mineral density was obtained on all patients within 2
nd
 week following 
acute spinal cord injury.  At the end of 20 weeks the scan was repeated to determine the change 
in bone mineral density. A second-generation single energy Wipro CT Sytec-4000 machine used 
for measurement of Quantitative computerized tomogram (QCT) Phantom values throughout the 
study period. Same Radiologist was authorized for the procedures throughout the study period.  
The Radiologist was blinded from knowing whether it was first or second QCT scan to prevent 
bias. The phantom values were converted into bone mineral density values for age and sex 
matched using QCT WIN software and print out was obtained. 
QCT measurement procedures 
       Patients with Spinal Cord Injury (Within 2 weeks following injury) were admitted following 
fulfilment of inclusion /exclusion criteria were subjected for first QCT analysis of spinal bone 
mineral density (QCT 1). All technical parameters were followed according to CT scanning 
instructions from user's guide.  Solid cylindrical calibration phantom using reference samples (0, 
50,100,200 mg/cc) used for collecting phantom values. 
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Patient positioning procedures  
The patient set -up procedure was similar to a lumbar spine series except that the patient was 
positioned on the QCT calibration phantom during the scans. The procedure was begun by 
placing the calibration phantom on the scanner cradle near the center of the scan range.  
The phantom placed within the cushion cutout with correct side up. Placed the bolus bag 
lengthwise on the phantom with the white insulated side up (this provides thermal insulation 
for patent comfort). 
 
 
 
Figure 2: QCT equipment 
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Figure 3: QCT table and calibrated Phantom 
                  
The patient was positioned on the phantom, bolus bag, and cushion with the end of phantom 
approximately at L5/S1, so L4 through T10 would be over the phantom. Thick clothing was 
removed and elevating the knees helped to flatten the back and achieve close contact with the 
phantom. A bolus bag (jell pack) was placed between the patient and the calibration phantom. It 
was used to remove air gaps that produce streaks, scatter and edge effects, which degrade the 
quantitative results. After fulfilling the various parameters according to user's guide a scout film 
was taken and identified the vertebrae to be scanned. . A 10 mm thick slice cut through the exact 
center of the vertebrae at an angle parallel to the endplates. Bone densities for 6 vertebral bodies 
(from T11 to L4) and phantom values and averaged to obtain a single result for the patient     
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Vertebral ROI placement:  
The vertebral ROI optimized to obtain the maximum (ideally 3-4 cm
2
) sample of trabecular bone 
and 2 pixels away from the cortical rim. The calibration phantom contains four samples of 
materials, which will appear on the CT image with 3 visibly different densities and an apparent 
blank space at the water (0 mg/cc) position. The known concentrations of calcium 
hydroxyapatite in the rods are (beginning with the densest [white] cylinder on the CT viewing 
monitor): 200 mg /cc, 100 mg/cc, 50 mg/cc, and 0 mg/cc.  
 
 
Figure 4: Calibrated Phantom 
               All data are entered in QCT win software and displayed on the screen to plot the 
individual BMD readings of each vertebra compared to the reference curve by age .The mean 
reference values, as a function of age, display as the central curve.  
The two additional outer curves represent +/- 1 standard deviation. Fracture prevalence is also 
shown by the colored regions where red is high, yellow is moderate, and green is low risk for 
fracture. The comparison of serial exams shows a graph of BMD results for the patient on 
repeated exams. The table lists each exam date, the mean BMD for each exam, the BMD change 
in mg/cc from the last exam.       
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Data Collection: 
            BMD values were obtained at the 2
nd
   week and 20
th
   weeks following spinal cord injury 
using QCT Scan.  A standardized pro-forma was used to enter patient information. This was 
entered in a computerized database. 
Data Analysis: 
            The primary outcome was the change in the bone mineral density. The differences 
between the first and second QCT was ascertained. The differences were compared for means of 
two independent samples, first and second QCT was compared for means of two correlated 
samples (paired t test). The results were analyzed using SPSS PC
+ 
for windows with the help 
of a qualified Clinical epidemiologist. 
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RESULTS 
DEMOGRAPHY 
Twenty acute spinal injured patients who fulfilled the selection criteria were recruited into the 
study. 
 
Table 1: Demography 
Demography
Age Mean 31.5 years Range 21 to 40
Gender Male 18 Female 2
Type of trauma Fall 14 Motor vehicle accident 4
Industrial accident 2
Neurological level Tetraplegia 10 Paraplegia 10
ASIA score Complete 10 Incomplete 10
Tone Spastic 14 Flaccid 6
 
Age distribution 
The mean age of patients recruited was 31.5 years, ranged between 21 to 40 years. 
Gender distribution 
There were eighteen males and two female patients participated in the study. 
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Causes of spinal cord injury 
Among 20 patients recruited in the study fourteen patients sustained injury due to fall, four 
from motor vehicle accident and another two by industrial accident. 
Neurological level 
There were ten patients each, grouped as tertaplegic and paraplegic respectively among the 
total twenty patients who were consented for the study.  
Completeness of spinal cord injury according to ASIA score 
There were ten complete and equal amount of incomplete patients were participated in the 
study. 
Tone 
Among twenty patients participated in the study, fourteen developed spasticity and remaining 
six were continue to flaccid. 
Associated injuries and other morbidities 
One patient developed haemothorax which was managed by chest drain. Three patients 
developed doppler ultra sound confirmed deep vein thrombosis and managed by oral 
anticoagulants. Two patients sustained long bone fractures of lower limbs simultaneously and 
managed conservatively. One patient sustained de-glove injury of lower limb and scrotum 
which was also managed conservatively. One patient diagnosed to have bipolar affective 
disorder after inclusion and another patient developed tonic-clonic seizures. These patients 
were managed with oral medications. One patient incidentally found to have vertebral 
hemangioma extending from T11 to L4. All the patients continued to participate in the study 
till 20 weeks.  
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Mobility at twenty weeks 
After completing 3 months immobilisation of spine, encouraged the patients for active 
mobilisation. At twenty weeks, among twenty patients three patients walked without any aid 
or appliances, eight walked with help of orthoses, three were ambulant using wheel chair and 
six patients were continued to be on bed rest. 
CHANGE IN BONE MINERAL DENSITY 
Variation between first and second BMD from the standard age and sex matched 
normal BMD values 
First BMD value in eighteen patients among twenty was at or above the standard age and sex 
matched normal. Two patients at first QCT itself was more than 1 standard deviation (SD) 
but less than 2 SD below age and sex matched normal (osteopenic range). These two patients 
at the end of 20 weeks fall 5 and 14 mg/cc respectively. Among those 18 patients, twelve 
were maintained the BMD value above normal at the end of 20 weeks. Six patients among 
above 18 patients showed significant fall in BMD from age and sex matched normal at the 
end of 20 weeks. Five patients among this 6 had a fall more than or equal to 1 SD (1 SD=27 
mg/cc) below age and sex matched normal (osteopenic range) and one had a fall less than 1 
SD. Among 20 patients in the study two patient‟s first BMD value was very much below 
normal and continued to fall at the end of 20 weeks.  
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Figure 5: Change in BMD from age & sex matched normal 
Change in BMD over 20 weeks 
On evaluating for fall in BMD from the first QCT to second without comparing to age and 
sex matched BMD, following observation was made.  
The mean difference of BMD change (fall in BMD) among 19 patients was 19.76 mg/cc 
(ranges 5 to 47 mg/cc). One patient showed rise in BMD from first QCT (5.8 mg/cc). 
Statistics 
Comparison of means of two correlated samples (first and second BMD) –  
The paired t-test 
The critical ratio t follows a t-distribution with 19 degrees of freedom. The t- distribution for 
19 degrees of freedom gives the 5% level as 2.093 and 1% level as 2.861. The observed 
critical ratio value 6.8 is more than 1% level. The test provides evidence to say that there is 
significant difference between first and second QCT value for change in BMD (P- value is 
more than 0.001). 
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Comparison of means of two independent samples – Tetraplegic and Paraplegic BMD 
The critical ratio t follows a t-distribution with 18 degrees of freedom. The t- distribution for 
18 degrees of freedom gives the 5% level as 2.101and 1% level as 2.878. The observed 
critical ratio value 0.2509 is less than 5% level. The test provides evidence to say that there is 
no significant difference in BMD value of first and second QCT among tetraplegic and 
paraplegic (p-value less than 0.05).  
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DISCUSSION 
Bone is constantly remodelling, with an increase in bone resorption, typically followed within 
30 to 40 days by the process of bone formation. With normal bone remodelling, there is no 
net change in the amount of bone mass present in young adults (9). In most forms of 
osteoporosis a disruption of bone remodelling occurs. The measurement of bone mineral 
content or density forms the basis for an operational definition of osteoporosis. The 
operational definition of osteoporosis is based on the distribution of skeletal mass in young 
healthy individuals by WHO (14). The relationship between bone mineral density and 
fracture risk is continuous, and an estimate of bone mineral density therefore provides an 
effective assessment of fracture risk (11).In any condition that causes immobilisation, loss of 
bone occurs and is correlated to the severity of unloading. The incidence of lower extremity 
fractures in SCI patients was found to be ranging from 1 to 34% (28, 44).  
In view of the importance of trying to prevent osteoporosis, a common complication in the 
SCI population (16), it was decided to quantify the incidence of vertebral osteoporosis in this 
study population. 
QCT allows for a three-dimensional true density measurement of bone without 
superimposition of other tissues and therefore provides exact three-dimensional anatomic 
localisation of the measured tissue (18). Bone density can be calculated separately in 
trabecular and cortical bone compartments. Selective measurement of high turnover 
trabecular bone, such as the central portion of the vertebral body, is of some advantage 
because it excludes cortical bone and extra osseous calcification. QCT results are expressed 
as mgm of K2HPO (dipotassium hydrogen orthophosphate) per cubic cm of bone volume, 
reflecting a true three dimensional density rather than the two dimensional area of DXA. 
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In this study, 20 acute spinal cord injured (SCI) patients, who fulfilled the inclusion criteria, 
were recruited. They were observed for 20 weeks to determine the incidence of occurrence of 
vertebral osteoporosis. 
There are several risk factors for secondary osteoporosis that could have affected the outcome 
of this study. The relevant risk factors include age, gender, neurological lesion and 
immobility and these are explored further below. 
Age 
SCI in Western populations occurs primarily in young adults, with more than half occurring 
in persons 16 to 30 years of age, and males account for about 80% of cases (45). The 
incidence and prevalence of osteoporosis consistently increases with age. During growth the 
trabecular bone of the skeleton matures to its peak density at around 16 to 20 years of age and 
then begins to decline gradually (47).  After a plateau in BMD around ages 30 to 45 years, a 
rapid decline in BMD occurs soon after menopause in women, followed by a gradual decline 
with age in both sexes (46). In this study the mean age of all the patients was 31.5 years 
(range 21 to 40) and therefore all the patients could be considered to be within this plateau 
period. Ross PD (46) in his review stated that, by definition, approximately 15% of young 
adults in the USA have osteopenia and only about 0.6% has osteoporosis.  In this study, 
based on an Indian population, 2 (10%) of the patients at the start of the study, and 5 (25%) 
of the patients at the end had osteopenia; none of the patients had developed osteoporosis. 
Roberts et al (16) followed up 30 acute SCI patients, average age 28.6 years (range from 13.8 
to 66.3 years), and they observed that the markers of bone resorption showed significant 
increase six months following injury, but markers of bone formation showed only a minor 
rise.  
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Garland DE et al (12) observed in his radiological studies, among SCI, that approximately 
one third of bone mineral is lost within 3 – 4 months of SCI, after which time the loss slows. 
Naftchi et al (48)
 
studied twenty acute SCI patients with a mean age of 25 years (range from 
19 to 40 years) and they also observed an increase in bone resorption markers in all patients.  
Szollar et al (49, 50) in two studies compared 263 and 240 chronic SCI patients respectively 
with 92 and 80 able bodied individuals. The spinal cord injured patients were at various times 
post injury (1 to 59 years), their mean age was 48.8 years (range from 20 to 78 years) and the 
able bodied individuals had a mean age of 51.1 years (range from 24 to 76 years).   Kannisto 
et al (47) studied thirty five adults who had sustained their injury in childhood, the median 
age at the time of injury was 12.9 years (range from birth to 17.1 years), the median age at the 
time of study was 31 years (range from 18 to 63 years) and the median time period from the 
injury was 19 years (range from 1.5 to 57 years). They observed a reduction in bone mineral 
density in the femoral region. Biering-Sorenson et al (51) studied twenty six patients (age 
range from 20 to 65 years) who had sustained their injury 2 to 25 years ago and observed a 
greater bone mineral content (BMC) reduction in the femur and tibia rather than the lumbar 
region. Leslie et al (52) looked at fourteen SCI patients, whose average age was 32.4 years, 
and the lumbar bone mineral density was found to be well preserved.  Needham-Shropshire et 
al (53) studied sixteen SCI patients whose average age was 28.8 years and mean duration post 
injury was 3.8 years. Demirel et al (3) studied forty one SCI patients and their mean age was 
35.8 years (range from 19 to 49 years).  
Gender 
There were 18 males and 2 females included in the study. This male: female ratio suggests 
that males are affected more commonly than females in traumatic SCI in India, however, 
since this is a hospital based study rather than a community based one, one cannot be 
categorical about the gender ratio.  
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Similar gender differences were observed in other studies (3, 16, 45, 47, 48, 50, 51, 52, 53). 
In the general population bone loss begins earlier and proceeds more rapidly in females than 
males, with an accelerated phase in postmenopausal years (54). As the numbers of females in 
this study population is very small, it is not possible to evaluate the difference in osteoporosis 
with regard to gender in the spinal cord injured population. 
Causes of spinal cord injury 
In this study the commonest cause of SCI was due to fall (n=14, 70%) from a height, where 
as in Western populations the majority of the SCI was due to motor vehicle accidents (45). 
Motor vehicle accidents are becoming more common in our country as well; despite this it is 
interesting that only 4 of the patients (20%) in this study had injuries secondary to motor 
vehicle accidents. 
Neurological Lesion 
There were 10 tetraplegic and 10 paraplegic patients and equal numbers of incomplete and 
complete SCI patients in this study group. There were 14 spastic patients and 6 flaccid 
patients. There was significant improvement (at least 1 neurological segment) in neurological 
status in all patients.  
Associated injuries and other morbidities  
There were a few patients with associated illnesses and injuries in this group that could have 
affected their bone mineral density. Some injuries prolonged the period of immobilisation, 
and some illnesses required drugs, which could have affected the BMD. One patient had a 
haemothorax that did not interfere with his mobilisation. Another patient had a de-glove 
injury of left lower limb, this delayed his mobilisation but he did not drop his BMD value 
into the osteoporotic range.  
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Three patients developed deep vein thromboses confirmed by Colour Doppler Ultrasound 
examination. All of them were put on intravenous heparin for 24 hours and then started on 
oral Nicoumalone, (Sintrom) a coumarin derivative.  15000 units heparin for a period of 6 
months or more has been reported to cause osteoporosis (55) but there are no reports that 
Sintrom causes osteoporosis. 
One patient was diagnosed as having a bipolar affective disorder and was treated with oral 
Risperidone, an anti psychotic drug, a benzisoxazole derivative.  Continuous use of this has 
not been reported to produce osteoporosis (56). Another patient was diagnosed to have 
generalised tonic clonic seizures and was managed by oral carbamazapine.  Phenytoin 
sodium is reported to produce osteoporosis, but carbamazapine is not (56).  One female 
tetraplegic was found to have a haemangioma in the vertebral body extending from thoracic 
11 to lumbar 4 on her spine QCT scout film.  This could be the reason for her initial very low 
BMD value (osteopenic range) but her drop from the first to the second QCT,  BMD (20.5 
mg/cc) was close to the average drop (19.76mg/cc ). 
Metabolic responses to SCI 
After an acute SCI, a patient‟s early metabolic response is presumably influenced by the 
hyper metabolism related to the injury and includes a negative nitrogen balance (57). Several 
speculations have been made concerning the aetiology of this negative nitrogen balance. For 
example immobility can cause wasting and break down of muscle protein (57),
 
which is 
detected by increased urinary nitrogen output, and leads to organ failure and death. It was 
demonstrated that obligatory nitrogen losses after SCI persists for approximately 7 weeks
 
post injury. Conversely the negative nitrogen balance found post injury may cause a loss of 
lean muscle mass (57) and so an excess production of metabolic acids. Denervation atrophy 
has also been hypothesised as being responsible for this phenomenon (57)
. 
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Acute SCI is often associated with injuries to other organ systems and is compounded by 
complications such as respiratory insufficiency and infection. These and the nutritional status 
will affect the catabolic status of the patient. 
A delayed chronic phase of metabolic response that is characterised by an obligatory loss of 
lean body mass, a marked reduction in substrate use, and decreased metabolic activity has 
been observed and extensively studied in SCI (57, 58).  In spinally injured patients, the 
nitrogen balance remains negative for a longer time frame; presumably partly due to the 
denervation of the lean muscle mass.  Other factors may contribute to this including the 
reduced level of mobility found in SCI patients. Rodriguez et al (57) concluded that acute 
immobilisation could, in part, be a cause of acute post-injury increase in nitrogen which 
observed in paralysed patients and SCI patients generally remain less mobile than the general 
population. 
In this study, the mean difference of BMD change (fall in BMD) was 19.76 mg/cc (ranges 5 
to 47 mg/cc). The average drop in BMD 19.76 mg/cc  from first to second QCT for all the 
patients was statistically significant (p > 0.001), consistent with Roberts et al findings (16). 
None of the patients BMD‟s dropped to the osteoporotic range. When one considers fracture 
threshold at an equivalent mineral density of about 110mg/cc (59), the incidence of 
osteoporosis in this study population of acute spinal cord injured patients is zero. However 2 
of the patients (10%) in the beginning of the study and 5 of the patients (25%) at the end had 
osteopenia but no patient in this group dropped their BMD to an osteoporotic level at the end 
of 5 months. This may be because it is too early to detect osteoporosis, but at a later stage it 
may be that the BMD continues to drop and will eventually reach the osteoporotic range. 
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Tetraplegia, paraplegia and bone turnover 
The literature relating to potential differences in bone turnover between tetraplegics and 
paraplegics is conflicting (3, 16, 52). The failure to clearly demonstrate differences between 
tetraplegics and paraplegics may reflect heterogenecity of these populations; patients with 
low tetraplegia can have sufficient use of their arms to propel themselves in a wheel chair, as 
do paraplegics. Thus functionally, some paraplegics and tetraplegics may not be very 
different, and their bone turnover would not be expected to be dissimilar.    
There was no difference in the first and second QCT (BMD) in paraplegics and tetraplegics 
in this study. There was no significant difference in BMD value of first and second QCT 
among tetraplegic and paraplegic (p < 0.05). Roberts et al (16) found no significant difference 
in absolute values of bone turnover markers between paraplegic and tetraplegics. They found 
one of the bone turnover markers, pyridinoline, was greater in tetraplegics but other markers 
did not show any increase.  Pyridinoline is a non-specific marker as it is also found in other 
connective tissue. As tetraplegics have more soft tissue turnover when compare to 
paraplegics, the pyridinoline level was naturally higher in tetraplegics. In contrast, 
deoxypyridinoline and N-telopeptide are more bone specific. Roberts et al concluded that 
there was a suggestion and not conclusive proof that quadriplegics may have a greater bone 
turnover than paraplegics.  
Spasticity and BMD 
Among twenty patients participated in the study, fourteen developed spasticity and remaining 
six were continue to be flaccid. There was no difference in the BMD with respect to tone. 
Comarr et al observed that lower motor neuron lesions were associated with a higher fracture 
risk than upper motor neuron lesions (60). Biering-Sorensen et al found that spasticity had no 
significant influence on the bone mineral content (51).  
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Leslie et al observed a weak positive association between femoral neck BMD and the 
Ashworth spasticity score but this was not statistically significant (52).  
Mobility and BMD 
There is evidence that the loss of gravitational loading plays a significant role as a stimulus 
in initiating the early resorptive state (52). Muscular loading of the bones has also been 
thought to play a role in the maintenance of bone density.  In this study there was no 
difference in the fall in BMD between those who were walkers, those who were wheelchair 
users and those who were bed bound. Biering- Sorensen et al observed that the average bone 
mineral content of the lumbar spine in spinal cord injured was a little higher than that of 
normal and concluded that the lumbar spine continues to be loaded while sitting on a wheel 
chair (51). This increase in lumbar spine BMD compared to the normal age sex matched 
BMD was not found in this study. They also did not find any significant difference in the 
BMD of the long bones or the vertebral bones in those using long leg braces every day.  
They concluded that the reason for not observing any difference in BMD between users and 
non-users of long leg braces is that long leg braces do not give rise to very much weight 
bearing on the long bones and the weight, to a great extent, is transmitted through the braces. 
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 LIMITATIONS OF THE STUDY 
 This study was designed to evaluate the vertebral osteoporosis in persons with acute 
spinal cord injury at the end of 20 weeks. Since spinal cord injury is a chronic 
disabling condition, continuing measurements at 1 year and beyond may give us a true 
picture of the extent of the ongoing vertebral osteoporosis.  
 Nearly all patients demonstrated a drop in bone mineral density, none of them 
dropped into osteoporotic range when measured by single energy quantitative 
computerised tomography (SEQCT). It is believed that dual energy quantitative 
computerised tomography (DEQCT) is more accurate; therefore using a more 
sensitive and accurate method like DEQCT may give us different results. However 
DEQCT exposes the person to a higher dose of radiation, which is a drawback. 
 A greater number of patients would have increased the reliability of the conclusions 
and the conclusions drawn from the subgroups like gender, level of lesions etcetera.      
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CONCLUSION 
 In the 20 patients with acute spinal cord injury studied, at 20 weeks after injury 95% 
showed decrease in their bone mineral density, 25% were osteopenic and none were 
osteoporotic. The incidence of vertebral osteoporosis in persons with acute spinal cord 
injury in this study is zero. 
 At 20 weeks the bone mineral density in persons with acute spinal cord injury was not 
affected by neurological status, mobility status or muscle tone. 
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 DATA SHEET 
 
Sr No Hosp No Age Gender Neurological 
level 
& 
ASIA Score 
Age/sex 
matched 
normal 
BMD 
First BMD Second BMD Change in BMD 
at end of 20 
weeks 
1 464161B 35 M C6 B 193.3 194.9 161.1 -33.8 
2 464395B 25 M C5A 211.9 215.1 187.5 -27.6 
3 472464B 27 M L2B 208.2 177.6 172.6 -5 
4 523046B 35 M T11B 193.3 302.2 268.6 -33.6 
5 496033B 30 M T7A 202.6 262.7 250.3 -12.4 
6 539254B 40 F T11B 178.6 192.1 183.8 -8.3 
7 543206B 31 M T11A 200.8 213.3 186.7 -26.6 
8 539851B 38 M C5B 187.8 208.0 197.3 -10.7 
9 546711B 27 M C3D 208.2 314.6 267.5 -47.1 
10 571062B 38 M C8A 187.8 215.2 197.0 -18.2 
11 566582B 28 M C5A 206.3 259.0 229.3 -29.7 
12 621696B 23 M C5B 215.6 242.1 230.3 -11.8 
13 630591B 37 F C5A 184.8 151.7 131.2 -20.5 
14 630661B 35 M C5B 195.5 225.0 230.8 +5.8 
15 646231B 21 M T10A 219.3 211.6 187.3 -24.3 
16 657381B 40 M T10A 184.0 201.7 185.0 -16.7 
17 048722B 25 M T5A 211.9 211.4 172.0 -39.4 
18 693776B 23 M T11B 215.6 212.1 194.6 -17.5 
19 699170B 35 M C5A 195.5 208.0 198.6 -9.4 
20 732346B 32 M L1B 199.0 208.4 200.1 -8.3 
